IDEAYA Biosciences Inc. is an oncology-focused precision medicine company developing targeted therapeutics for patient populations selected using molecular diagnostics.
Shares of Silk Road Medical Inc (SILK), which made their stock market debut in April, have since gained nearly 40%.
Shares of NeoGenomics Inc. (NEO), which have been hitting new highs, are up nearly 87% year-to-date.
In the healthcare sector, 2 companies made their debut on the NASDAQ in the first week of May - TransMedics Group (TMDX) at an offering price of $16 per share, and So-Young International (SY) at $13.80 per share.
Legal cannabis was one of the dominating headlines in 2018. Canada's legalization of marijuana for recreational use, legalization of recreational and medicinal marijuana in a number of U.S states, and FDA approval of the first cannabis-based medication, Epidiolex, to treat rare, severe forms of epilepsy have galvanized interests and investments in this sector.
Andover, Massachusetts-based TransMedics, Inc. is a commercial-stage medical device company whose proprietary system, Organ Care System, enables transplantation of beating hearts and other functioning organs.
Shares of INmune Bio Inc. (INMB) touched an all-time high of $11 on Tuesday (Apr.16), and that represents a gain of nearly 38% since their market debut in February.
Jerusalem, Israel-based Brainsway is a commercial stage medical device company marketing non-invasive neuromodulation products for the treatment of major depressive disorder and obsessive-compulsive disorder.
Shares of Moderna Therapeutics Inc. (MRNA), which had a splashy IPO last December, raising $604 million, considered the biggest-ever biotech IPO, touched a new high last week.
Shares of Denali Therapeutics Inc. (DNLI) touched an all-time high of $26.93 on Wednesday, which represents a year-to-date gain of 32%.
In the healthcare sector, 1 company made its stock market debut in January, 12 in February, and 3 companies went to public in March.
Loos, France-based Genfit S.A. is a late-stage clinical biopharmaceutical company developing innovative drug candidates and diagnostic solutions for metabolic and liver-related diseases.
Shares of Ascendis Pharma A/S (ASND) closed yesterday's trading at an all-time high of $125.29, and that represents a gain of nearly 100% year-to-date.
Shares of Lantheus Holdings Inc. (LNTH) are up an impressive 53% year-to-date, way ahead of the iShares Nasdaq Biotechnology ETF (IBB) index, which has gained only 20% during the same period.
Santa Clara, California-based ShockWave Medical Inc. is a medical device company developing and marketing products based on intravascular lithotripsy (IVL) technology to treat calcified cardiovascular disease.